This was also observed in a breast cancer diagnostic study; they used fluorescein HS-27 in combination with HSP90 to provide a cost-effective and easy-to-implement diagnostic platform (Crouch et al., 2019). The gene discussed is HSP90AA1; the disease is breast carcinoma.